Article

Rheumatoid Arthritis Biosimilar Development Highlights Week in Specialty Pharmacy

Author(s):

Davy James, Managing Editor

Top news of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/rheumatoid-arthritis-biosimilar-development-highli" target="_blank">View the story "Rheumatoid Arthritis Biosimilar Development Highlights Week in Specialty Pharmacy" on Storify</a>]

Related Videos
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Related Content
Medical model of chronic kidney disease -- Image credit: kanruthai | stock.adobe.com
January 20th 2025

Study Shows Potential Population-Level Benefits of Intensive BP Targets in Adults With CKD

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Blood sample testing for hepatitis B virus -- Image credit: gamjai | stock.adobe.com
January 17th 2025

Xalnesiran Plus Immunomodulator Results in HBsAg Loss Among Patients With Chronic Hepatitis B

Gillian McGovern, Associate Editor
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

CMS, HSS, Negotiated Drug Prices, Inflation Reduction Act | Image Credit: Oleg | stock.adobe.com
January 17th 2025

HHS Announces Next 15 Drugs for Medicare Part D Price Negotiations

Ashley Gallagher, Editor
Liver affected with hepatitis -- Image credit: Rasi | stock.adobe.com
January 15th 2025

IL-8+ Neutrophils Can Be Key in Therapeutic Developments for Alcohol-Associated Hepatitis

Gillian McGovern, Associate Editor